Fish Oil and Probiotics in Pregnancy

Fish Oil and Probiotics in Pregnancy (FOPP) study

FOPP, which stands for Fish Oil and Probiotics in Pregnancy, describes the focus of the study: fish oil and probiotics consumption by pregnant women and impacts on gut microbiota, metabolism and health of both the mother and the child. This clinical study began at the University of Turku and Turku University Hospital in the autumn of 2013, when women in early pregnancy were recruited, and the 5 to 6-year postpartum visits were completed in 2023.

The aims of the study are to determine whether probiotics and/or fish oil supplements can decrease the risk of gestational diabetes mellitus and to beneficially impact maternal weight and body composition during and after pregnancy. We are also investigating whether these supplements could influence the immune system of the child and thus potentially decrease the risk of allergy. Further, we study dietary intake, lipid metabolism, low-grade inflammation and gut and vaginal microbiota.​ In more general terms, this study will provide answers to how maternal diet should be modified in order to induce health benefits in both the mother and the child including the risk for glucose disorders and overweight. Also, the mechanisms of the underlying health effects will be enlightened. We also have an interest in food choice and eating behavior as determinants of dietary intake and health. Our study setup allows investigation of the long-term impacts of maternal nutrition during pregnancy on both maternal and child health. Further the impacts of child nutrition and metabolism on her/his own metabolic and clinical health as well as growth and development, including neurocognitive development are investigated.

Study Results and Related Publications

Improved breast milk proteome coverage by DIA based LC-MS/MS method
The impact of fish oil and/or probiotics on serum fatty acids and the interaction with low-grade inflammation in pregnant women with overweight and obesity: secondary analysis of a randomised controlled trial
Maternal fish oil and/or probiotics intervention: Allergic diseases in children up to two years old
The Effect of a Fish Oil and/or Probiotic Intervention from Early Pregnancy Onwards on Colostrum Immune Mediators: A Randomized, Placebo-Controlled, Double-Blinded Clinical Trial in Overweight/Obese Mothers
Gut microbiota composition and function in pregnancy as determinants of prediabetes at two-year postpartum
Aberrations in the early pregnancy serum metabolic profile in women with prediabetes at two years postpartum
Maternal obesity, gestational diabetes mellitus, and diet in association with neurodevelopment of 2-year-old children
Fish Oil And/Or Probiotics Intervention in Overweight/Obese Pregnant Women and Overweight Risk in 24-Month-Old Children
Potential pathobionts in vaginal microbiota are affected by fish oil and/or probiotics intervention in overweight and obese pregnant women
Distinct Diet-Microbiota-Metabolism Interactions in Overweight and Obese Pregnant Women: a Metagenomics Approach
Serum CathepsinD in pregnancy: Relation with metabolic and inflammatory markers and effects of fish oils and probiotics
A healthy dietary pattern with a low inflammatory potential reduces the risk of gestational diabetes mellitus
Impact of combined consumption of fish oil and probiotics on the serum metabolome in pregnant women with overweight or obesity
Weight gain and body composition during pregnancy: a randomised pilot trial with probiotics and/or fish oil
The Impacts of Fish Oil and/or Probiotic Intervention on Low-Grade Inflammation, IGFBP-1 and MMP-8 in Pregnancy: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial
Early pregnancy serum IGFBP-1 relates to lipid profile in overweight and obese women
Metagenomics analysis of gut microbiota in response to diet intervention and gestational diabetes in overweight and obese women: a randomised, double-blind, placebo-controlled clinical trial
Distinct Metabolomic Profile Because of Gestational Diabetes and its Treatment Mode in Women with Overweight and Obesity
GlycA, a novel marker for low grade inflammation, reflects gut microbiome diversity and is more accurate than high sensitive CRP in reflecting metabolomic profile
Efficacy of Fish Oil and/or Probiotic Intervention on the Incidence of Gestational Diabetes Mellitus in an At-Risk Group of Overweight and Obese Women: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial
Overweight and obesity status in pregnant women are related to intestinal microbiota and serum metabolic and inflammatory profiles
Dietary quality influences body composition in overweight and obese pregnant women
The impact of probiotics and n-3 long-chain polyunsaturated fatty acids on intestinal permeability in pregnancy: a randomised clinical trial
Gut microbiota aberrations precede diagnosis of gestational diabetes mellitus
Evaluation of serum zonulin for use as an early predictor for gestational diabetes
Increased intestinal permeability, measured by serum zonulin, is associated with metabolic risk markers in overweight pregnant women
Gut Microbiota Richness and Composition and Dietary Intake of Overweight Pregnant Women Are Related to Serum Zonulin Concentration, a Marker for Intestinal Permeability